| Date Filed | Type | Description |
| 03/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/14/2023 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 44,275 shares
@ $0
Granted 22,459 shares
@ $0
Paid exercise price by delivering 14,529 shares
@ $26.75, valued at
$388.7k
Paid exercise price by delivering 6,797 shares
@ $26.75, valued at
$181.8k
|
|
| 01/11/2023 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 10,424 shares
@ $27.08, valued at
$282.3k
Sold 7,341 shares
@ $27.83, valued at
$204.3k
Sold 69 shares
@ $28.58, valued at
$2k
|
|
| 07/13/2022 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 594 shares
@ $17.48, valued at
$10.4k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 52,500 shares
@ $0
Granted 13,675 shares
@ $0
Paid exercise price by delivering 6,643 shares
@ $17.63, valued at
$117.1k
Paid exercise price by delivering 4,016 shares
@ $17.63, valued at
$70.8k
|
|
| 01/12/2022 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 701 shares
@ $19.05, valued at
$13.4k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2021 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 595 shares
@ $23.17, valued at
$13.8k
|
|
| 02/12/2021 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 1,901 shares
@ $25.95, valued at
$49.3k
Paid exercise price by delivering 3,283 shares
@ $25.95, valued at
$85.2k
Sold 2,100 shares
@ $24.89, valued at
$52.3k
Sold 5,798 shares
@ $25.33, valued at
$146.9k
|
|
| 01/22/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2020 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 8,000 shares
@ $24, valued at
$192k
Exercised 8,000 options to buy
@ $15.9, valued at
$127.2k
|
|
| 05/15/2020 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 4,434 shares
@ $22.61, valued at
$100.3k
|
|
| 02/12/2020 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 1,966 shares
@ $21.62, valued at
$42.5k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/16/2020 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 1,321 shares
@ $23.87, valued at
$31.5k
|
|
| 01/14/2020 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 702 shares
@ $23.3, valued at
$16.4k
|
|
| 07/12/2019 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 1,190 shares
@ $12.44, valued at
$14.8k
Sold 2,857 shares
@ $12.31, valued at
$35.2k
|
|
| 01/29/2019 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 25,600 shares
@ $0
Granted 25,600 options to buy
@ $15.9, valued at
$407k
|
|
| 07/12/2018 |
4
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 16,186 shares
@ $0 |
|
| 07/12/2018 |
3
| Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 3 on COLLEGIUM PHARMACEUTICAL, INC |